Evidence map›Paper›PMID 41237221›Full record

ArticleScience immunology2025

CD21 primes extrafollicular differentiation of autoreactive B cells in a TLR7-driven lupus model.

Danni Y Zhu, Daniel P Maurer, Carlos Castrillon, Yixiang Deng, Faez A N Mohamed, Minghe Ma, David Tang, Jessica Min-Debartolo, Nathan Higginson-Scott, Janet Buhlmann and 3 more

Abstract read
In one paragraph

Article in Science immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Danni Y ZhuProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, USA.ORCID 0000-0001-6327-8673
Daniel P MaurerHarvard Graduate Program in Virology, Boston, USA.ORCID 0000-0003-2074-5416
Carlos CastrillonDepartment of Medicine, Emory University School of Medicine, Atlanta, USA.ORCID 0000-0003-2909-7371
Yixiang DengRagon Institute of Mass General, MIT, and Harvard, Cambridge, USA.
Faez A N MohamedRagon Institute of Mass General, MIT, and Harvard, Cambridge, USA.
Minghe MaProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, USA.ORCID 0000-0002-4496-6240
David TangPfizer Centers for Therapeutic Innovation, Boston, USA.
Jessica Min-DebartoloPfizer Centers for Therapeutic Innovation, Boston, USA.ORCID 0000-0002-1554-8365
Nathan Higginson-ScottPfizer Centers for Therapeutic Innovation, Boston, USA.ORCID 0009-0006-7163-3296
Janet BuhlmannPfizer Centers for Therapeutic Innovation, Boston, USA.
Aaron G SchmidtDepartment of Microbiology, Harvard Medical School, Boston, USA.ORCID 0000-0003-3627-2553
Daniel LingwoodRagon Institute of Mass General, MIT, and Harvard, Cambridge, USA.ORCID 0000-0001-5631-9238
Michael C CarrollProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, USA.ORCID 0000-0002-3213-4295

Funding

Virology CoreP01AI089618 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI STEPHEN COPLAN HARRISON · 2011 to 2026
$40.0M
Epitope focusing to the receptor binding motif for a universal coronavirus vaccineR01AI146779 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SCHMIDT, AARON GREGORY · 2019 to 2023
$4.2M
Evolution of autoreactive GC and epitope spreading in lupusR01AR074105 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI Michael Craig Carroll · 2018 to 2026
$4.2M
SARS-CoV-2 Variant TestingR01AI146785 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LINGWOOD, DANIEL · 2020 to 2024
$3.3M
FDC regulation of self-reactive B cellsR01AI130307 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI CARROLL, MICHAEL CRAIG · 2018 to 2022
$2.7M
Innate-like BCR activity as a template for universal vaccination against influenza virusR01AI137057 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CHACKERIAN, BRYCE C, LINGWOOD, DANIEL · 2018 to 2022
$2.6M
Triggering germline-encoded broadly neutralizing antibody responses against influenza virusR01AI153098 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BATISTA, FACUNDO DAMIAN, LINGWOOD, DANIEL · 2020 to 2023
$2.1M
Systemic coordination of pro-inflammatory immune reactions through dendritic cell-restricted sIL6R biogenesisR01AI155447 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LINGWOOD, DANIEL · 2021 to 2025
$2.0M
Sex differences in a cytokine controlling antibody class switch recombinationR21AI193280 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LINGWOOD, DANIEL · 2025 to 2025
$439k
NIAID NIH HHS P01 AI089618NIAID NIH HHS R01 AI130307NIAID NIH HHS R01 AI137057NIAID NIH HHS R01 AI146779NIAID NIH HHS R01 AI146785NIAID NIH HHS R01 AI153098NIAID NIH HHS R01 AI155447NIAID NIH HHS R21 AI193280NIAMS NIH HHS R01 AR074105
6 · The paper itself

Abstract

The extrafollicular (EF) B cell differentiation pathway has emerged as a prominent source of autoantibody-secreting cells (ASCs) in systemic lupus erythematosus (SLE). CD21

Indexed as

B-LymphocytesCell DifferentiationLupus Erythematosus, SystemicReceptors, Complement 3dToll-Like Receptor 7AnimalsAutoantibodiesAutoimmunityDisease Models, AnimalFemaleMembrane GlycoproteinsMiceMice, Inbred C57BLAutoantibodiesMembrane GlycoproteinsReceptors, Complement 3dTlr7 protein, mouseToll-Like Receptor 7

Identifiers

PMID41237221
PMCPMC13123569

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.